Stock Events

Stock Events

Nexalin Technology 

$0.36
35
+$0.01+3.71% Today

Statistics

Day High
0.41
Day Low
0.33
52W High
2.31
52W Low
0.33
Volume
14,931,421
Avg. Volume
305,005
Mkt Cap
6.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 7
$0.31
Jan 7
$0.31
Oct 6
$0.31
Jul 6
$0.31
Apr 6
$0.31
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

3JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.25
-0.2
-0.15
-0.1
Expected EPS
-0.1
Actual EPS
N/A

Financials

-4,501.18%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
338,000Revenue
-15.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. competes in the medical devices sector, offering products that could be seen as alternatives to Nexalin's technology for treating conditions like anxiety and depression.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc is a global leader in medical technology, services, and solutions, including neuromodulation devices that compete with Nexalin's offerings.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories operates in various segments, including neuromodulation, making it a competitor in the market for therapeutic devices similar to Nexalin's.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation is involved in the development, manufacturing, and marketing of medical devices that compete in the neuromodulation space.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew plc offers medical devices that can be used in treatments that compete with Nexalin's technology, particularly in the area of pain management and rehabilitation.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation is a technology company that offers products in medical and surgical, which could compete with Nexalin's approach to treating neurological conditions.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences Corporation is known for its innovations in patient-focused medical technologies, including those that could compete with Nexalin's neuromodulation devices.
Integra Lifesciences
IART
Mkt Cap725.6M
Integra LifeSciences Holdings Corporation offers products in neurosurgery and other medical device areas, potentially competing with Nexalin's technology.
Globus Medical
GMED
Mkt Cap11.89B
Globus Medical, Inc. is engaged in the design, development, and commercialization of musculoskeletal solutions, which may indirectly compete with Nexalin's neuromodulation therapies for pain management.

About

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Show more...
CEO
Mr. Mark White
Employees
6
Country
US
ISIN
US65345B2016

Listings

XNAS
US
NXL
BOATS
BOATS
NXL.BOATS

0 Comments

Share your thoughts

FAQ

What is Nexalin Technology stock price today?▼
The current price of NXL is $0.36 USD — it has increased by +3.71% in the past 24 hours. Watch Nexalin Technology stock price performance more closely on the chart.
What is Nexalin Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nexalin Technology stocks are traded under the ticker NXL.
Is Nexalin Technology stock price growing?▼
NXL stock has risen by +10.2% compared to the previous week, the month change is a -14.81% fall, over the last year Nexalin Technology has showed a -78.09% decrease.
What is Nexalin Technology market cap?▼
Today Nexalin Technology has the market capitalization of 6.77M
When is the next Nexalin Technology earnings date?▼
Nexalin Technology is going to release the next earnings report on June 03, 2026.
What were Nexalin Technology earnings last quarter?▼
NXL earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.12 USD resulting in a -8.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nexalin Technology revenue for the last year?▼
Nexalin Technology revenue for the last year amounts to 338,000 USD.
What is Nexalin Technology net income for the last year?▼
NXL net income for the last year is -15.21M USD.
Does Nexalin Technology pay dividends?▼
Yes, NXL dividends are paid quarterly. The last dividend per share was 0.31 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Nexalin Technology have?▼
As of April 09, 2026, the company has 6 employees.
In which sector is Nexalin Technology located?▼
Nexalin Technology operates in the Health Care sector.
When did Nexalin Technology complete a stock split?▼
Nexalin Technology has not had any recent stock splits.
Where is Nexalin Technology headquartered?▼
Nexalin Technology is headquartered in Houston, US.